Company Profile · Healthcare

Cardinal Health Inc

CAH · US
Exchange
US
Country
USA
IPO date
Dec 31, 1987
Employees
53,084
Current Price
$221.77
Live · Jun 18, 2026
Baillie Growth Score
41/100
Weak
Intrinsic Value · Three-Tier Range Current price $221.77 Live · Between the fair and optimistic ranges

Composite valuation range · conservative $130–$160 / fair $175–$215 / optimistic $240–$300. At $221.77, Between the fair and optimistic ranges.

At publication $200.68 (May 24, 2026)

No reports on this stock in your language yet.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Market cap$53B
Revenue (TTM)$250.74B
EBITDA$3.99B
Profit margin0.62%
ROE0%
P/E (TTM)34.6
Forward P/E19.05
PEG1.4
EPS$6.54
Dividend yield0.9%
52-week range$136.63 – $233.04
Analyst target$245.27
Analyst rating4.1 / 5

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.